Stocks
Bristol Myers Q3 Beat Fails to Shift Our Stock Caution
Bristol Myers just posted a solid Q3 beat and hiked full-year sales guidance to $47.5B-$48B. Shares jumped 6%, but we...
30/10/2025
2 views